Cancer

BIO5's interdisciplinary approach to scientific research has resulted in disease prevention strategies and promising new therapies, innovative diagnostics and devices, and improved food crops.

Meredith Mitstifer fought and survived ovarian cancer while she was pregnant with her son, Ryan. Now, Ryan works with Dr. Jennifer Barton to develop a new screening tool for ovarian cancer in hopes that no child will have to grow up without their moms.

A UArizona project, with funding from the state's New Economy Initiative, creates humanlike cancer models and growth environments to help improve prevention, diagnosis and treatment.

Tech Launch Arizona sits down with the Director of The BIO5 Institute, Dr. Jennifer Barton to hear about her experience as a researcher, inventor, and advocate for commercialization within the innovation ecosystem supported by TLA.

Hear from Dr. Jeff Burgess about a new Regents’ Research Grant. UArizona will lead a study in collaboration with other institutions across the state to test whether blood or plasma donations can lower levels of cancer-causing chemicals.

Through a recently approved Regents’ Research Grant, UArizona will lead a study, in partnership with the Arizona Fire Chiefs Association and Arizona State University, to target enrolling 1,500 Arizona firefighters to test the effectiveness of whether blood or plasma donations lower cancer-causing “forever chemicals” levels.

A $4 million Regents’ Research Grant will allow researchers to test new ways to reduce the risk of occupational-related cancer for firefighters.

Dr. Jianqin Lu, an assistant professor of pharmaceutics and pharmacokinetics at the University of Arizona R. Ken Coit College of Pharmacy, has received the Pharmaceutics Research Award from the American Association of Colleges of Pharmacy (AACP).

Dr. Mark Van Dyke discusses the post-pandemic importance of in-person meetings, collaboration, and discovery - especially in an innovation ecosystem like UArziona's where there are impactful innovations all around campus.

UArizona researchers have been working for decades to develop a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects.